Lucas Brent T., CEO of Envoy Medical, Inc. ($COCH), made one open market purchase of company shares in the last 365 days, totaling $25,000. His most recent buy occurred on February 12, 2026. This ranks him 3603rd among nearly 5,000 insiders by purchase amount, below the average of about $1.5 million across 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | Envoy Medical, Inc. | $COCH | Lucas Brent T. | Chief Executive Officer | P | Warrant (right to buy) | 62500 | $0.00 | 173,487.0000 | 21,851,606 | 56.31% | 0.29% |
| Feb. 12, 2026 | Envoy Medical, Inc. | $COCH | Lucas Brent T. | Chief Executive Officer | P | Warrant (right to buy) | 37500 | $0.00 | 148,487.0000 | 21,851,606 | 33.79% | 0.17% |
| Feb. 12, 2026 | Envoy Medical, Inc. | $COCH | Lucas Brent T. | Chief Executive Officer | P | Class A Common Stock | 62500 | $0.40 | 297,090.0000 | 21,851,606 | 26.64% | 0.29% |
| Feb. 5, 2026 | Envoy Medical, Inc. | $COCH | Lucas Brent T. | Chief Executive Officer | A | Stock Option (right to buy) | 200000 | $0.00 | 1,079,749.0000 | 21,851,606 | 22.73% | 0.92% |
| Nov. 28, 2025 | Envoy Medical, Inc. | $COCH | Lucas Brent T. | Chief Executive Officer | A | Class A Common Stock | 18105 | $0.71 | 234,590.0000 | 21,851,606 | 8.36% | 0.08% |
| Nov. 30, 2024 | Envoy Medical, Inc. | $COCH | Lucas Brent T. | Chief Executive Officer | A | Class A Common Stock | 5165 | $1.94 | 208,743.0000 | 18,616,362 | 2.54% | 0.03% |
| May 30, 2025 | Envoy Medical, Inc. | $COCH | Lucas Brent T. | Chief Executive Officer | A | Class A Common Stock | 7742 | $1.29 | 216,485.0000 | 21,326,609 | 3.71% | 0.04% |
| Dec. 11, 2024 | Envoy Medical, Inc. | $COCH | Lucas Brent T. | Chief Executive Officer | P | Warrant (right to buy) | 16694 | $0.06 | 110,987.0000 | 18,616,362 | 17.70% | 0.09% |
| Dec. 11, 2024 | Envoy Medical, Inc. | $COCH | Lucas Brent T. | Chief Executive Officer | P | Warrant (right to buy) | 94293 | $0.06 | 94,293.0000 | 18,616,362 | 9999.99% | 0.51% |
| June 24, 2024 | Envoy Medical, Inc. | $COCH | Lucas Brent T. | Chief Executive Officer | J | Class A Common Stock | 10176 | $0.00 | 216,298.0000 | 18,599,982 | 4.94% | 0.05% |
| June 24, 2024 | Envoy Medical, Inc. | $COCH | Lucas Brent T. | Chief Executive Officer | J | Class A Common Stock | 74784 | $0.00 | 216,298.0000 | 18,599,982 | 52.85% | 0.40% |
| Nov. 21, 2023 | Envoy Medical, Inc. | $COCH | Lucas Brent T. | Chief Executive Officer | P | Class A Common Stock | 10000 | $0.98 | 128,958.0000 | 11,215,068 | 8.41% | 0.09% |
| Nov. 21, 2023 | Envoy Medical, Inc. | $COCH | Lucas Brent T. | Chief Executive Officer | P | Class A Common Stock | 2380 | $0.92 | 131,338.0000 | 11,215,068 | 1.85% | 0.02% |
| Oct. 15, 2023 | Envoy Medical, Inc. | $COCH | Lucas Brent T. | Chief Executive Officer | A | Stock Option (right to buy) | 879749 | $0.00 | 879,749.0000 | 11,215,068 | 9999.99% | 7.84% |